East Africa Generic Drug Market Size, Growth Factors, Key Players, and Forecast 2022-2027

According to IMARC Group's latest report, titled "𝐄𝐚𝐬𝐭 𝐀𝐟𝐫𝐢𝐜𝐚 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟐-𝟐𝟎𝟐𝟕", The East Africa generic drug market size reached US$ 2.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 6.97% during 2022-2027.

Generic drugs refer to medications that contain same active ingredients and have same therapeutic effects as that of their branded counterparts. These drugs may differ in packaging but are identical in quality, strength, dosage, performance, efficiency, etc. As they are cost-efficient, the demand for generic drugs is escalating across the East African region.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/east-africa-generic-drug-market/requestsample

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

𝐄𝐚𝐬𝐭 𝐀𝐟𝐫𝐢𝐜𝐚 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

The elevating levels of urbanization, along with the improving healthcare facilities in the East African region, are primarily driving the generic drug market. Besides this, numerous government bodies are introducing price control policies and import restrictions to encourage domestic drug manufacturing. This, in turn, is further augmenting the market growth.

In addition to this, the rising prevalence of sedentary consumer lifestyles, along with increasing incidences of heart diseases, cancer, diabetes, obesity, etc., will continue to propel the demand for generic drugs across East Africa in the coming years.

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰:https://www.imarcgroup.com/checkout?id=3275&method=1

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The report has categorized the market based on segment, therapy area, drug delivery and distribution channel.

Breakup by Segment:
• Unbranded Generics
• Branded Generics

Breakup by Therapy Area:
• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Breakup by Drug Delivery:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakup by Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies

Breakup by Country:
• Uganda
• Burundi
• Rwanda
• Kenya
• Tanzania
• Others

𝐀𝐬𝐤 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐓𝐎𝐂 & 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐅𝐢𝐠𝐮𝐫𝐞𝐬: https://www.imarcgroup.com/request?type=report&id=3275&flag=C

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐈𝐌𝐀𝐑𝐂 𝐆𝐫𝐨𝐮𝐩:
Precision Medicine Market: https://www.imarcgroup.com/precision-medicine-market

Smart Pills Market: https://www.imarcgroup.com/smart-pills-market

Latin America Generic Drug Market: https://www.imarcgroup.com/latin-america-generic-drug-market

North Africa Generic Drug Market: https://www.imarcgroup.com/north-africa-generic-drug-market

West Africa Generic Drug Market: https://www.imarcgroup.com/west-africa-generic-drug-market

Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.